A. Toubaji

发表

The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection.

R. M. Simpson, J. Berzofsky, S. Khleif, 2007, Vaccine.

GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

E. Platz, G. Netto, M. Hoque, 2014, The Journal of urology.

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

A. Weeraratna, P. Argani, A. D. De Marzo, 2012, Breast Cancer Research.

Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.

A. Lenis, V. Reuter, I. Ostrovnaya, 2022, JCO precision oncology.

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

S. Steinberg, H. Parnes, J. Trepel, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Ipsilateral hemigland prostate biopsy may underestimate cancer burden in patients with unilateral mpMRI-visible lesions

Enis Cagatay Yilmaz, M. Merino, S. Harmon, 2022, Abdominal Radiology.

Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer: Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry

M. Berger, P. Russo, V. Reuter, 2014, The American journal of surgical pathology.

Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers

C. Iacobuzio-Donahue, P. Argani, A. D. De Marzo, 2011, Oncotarget.

Androgen-induced TOP2B mediated double strand breaks and prostate cancer gene rearrangements

Martin J. Aryee, Jianfeng Xu, William B. Isaacs, 2010, Nature Genetics.

ERG gene rearrangements are common in prostatic small cell carcinomas

C. Bieberich, J. Hicks, A. Marzo, 2011, Modern Pathology.

PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas

J. Hicks, A. D. De Marzo, J. Epstein, 2015, The Prostate.

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas

A. Partin, P. Walsh, W. Isaacs, 2011, Modern Pathology.

Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas

J. Hicks, E. Platz, A. D. De Marzo, 2011, The American journal of surgical pathology.

TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma

W. Isaacs, E. Platz, J. Epstein, 2009, Modern Pathology.

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas

E. Platz, J. Epstein, G. Netto, 2009, Modern Pathology.

618 IMMUNOHISTOCHEMISTRY FOR ERG EXPRESSION AS A SURROGATE FOR TMPRSS2-ERG FUSION DETECTION IN PROSTATIC ADENOCARCINOMA

J. Hicks, E. Platz, G. Netto, 2011 .

Identification of the PTEN-ARID4B-PI3K pathway reveals the dependency on ARID4B by PTEN-deficient prostate cancer

R. Wu, A. Toubaji, In-Chi Young, 2019, Nature Communications.

Profiling the expression pattern of GPI transamidase complex subunits in human cancer

G. Netto, B. Trink, D. Sidransky, 2008, Modern Pathology.

Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases.

J. Hicks, E. Platz, A. D. De Marzo, 2012, Human pathology.

Does Valproic Acid Induce Neuroendocrine Differentiation in Prostate Cancer?

A. Sidana, G. Netto, M. Carducci, 2010, Journal of biomedicine & biotechnology.

Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors

J. Hicks, A. Marzo, J. Epstein, 2008, Modern Pathology.

Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues

J. Hicks, A. D. De Marzo, G. Netto, 2008, The Prostate.

A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma

S. Steinberg, J. Berzofsky, W. Linehan, 2010, Journal of Translational Medicine.

Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers

F. Marincola, D. Venzon, S. Khleif, 2008, Cancer Immunology, Immunotherapy.

Extracellular matrix associated protein CYR61 is linked to prostate cancer development.

E. Platz, G. Netto, A. Mondul, 2010, The Journal of urology.

Prediction of histologic grade and type of small (< 4 cm) papillary renal cell carcinomas using texture and neural network analysis: a feasibility study

A. Toubaji, S. Haji-Momenian, Zirong Chen, 2021, Abdominal Radiology.

Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy.

J. Epstein, E. Schaeffer, G. Netto, 2009, The Journal of urology.

CHROMOSOME 21 COPY NUMBER BUT NOT TMPRSS2-ERG FUSION PREDICTS OUTCOME IN PROSTATIC ADENOCARCINOMA: A LARGE CASE-CONTROL RADICAL PROSTATECTOMY COHORT ANALYSIS

G. Netto, R. Albadine, A. Toubaji, 2009 .

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

A. Weeraratna, P. Argani, A. D. De Marzo, 2012, Breast Cancer Research.

Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers.

Enis Cagatay Yilmaz, S. Harmon, P. Pinto, 2023, Radiology.

Primary cardiac angiosarcoma: a rare tumor

A. Toubaji, J. Aziz, A. Chen, 2017 .

Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas

J. Hicks, E. Platz, A. D. De Marzo, 2011, The American journal of surgical pathology.

A novel MRI/ultrasound fusion prostate biopsy technique using transperineal ultrasound: An initial experience.

P. Pinto, Sheng Xu, B. Turkbey, 2023, Urology.

Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues

J. Hicks, A. D. De Marzo, S. Jadallah, 2008, The Prostate.